Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Nanoformulation of natural products for prevention and therapy of prostate cancer.

Literature DB >> 23201598

Nanoformulation of natural products for prevention and therapy of prostate cancer.

Vanna Sanna¹, Imtiaz A Siddiqui², Mario Sechi¹, Hasan Mukhtar³.

Abstract

There is a need for developing improved therapeutic options for the management of prostate cancer, able to inhibit proliferation of precancerous and malignant lesions and/or to improve the effectiveness of conventional chemopreventive and chemotherapeutic agents. In this perspective, application of nanotechnology based strategies for the delivery of natural compounds for effective management of the disease is being actively researched. Here, after highlighting the most promising natural compounds for chemoprevention and chemotherapy of prostate cancer, the state of the art nanotherapeutics and the recent proof-of-concept of "nanochemoprevention", as well as the clinical development of promising targeted nanoprototypes for use in the prostate cancer treatment are being discussed.

Entities: CellLine Chemical Disease Gene Species

Mesh：

Substances：

Year: 2012 PMID： 23201598 PMCID： PMC3890375 DOI： 10.1016/j.canlet.2012.11.037

Source DB: PubMed Journal: Cancer Lett ISSN： 0304-3835 Impact factor: 8.679

143 in total

1. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.

Authors: Anindita Mukerjee; Jamboor K Vishwanatha
Journal: Anticancer Res Date: 2009-10 Impact factor: 2.480

2. A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma.

Authors: Aminah Jatoi; Neil Ellison; Patrick A Burch; Jeff A Sloan; Shaker R Dakhil; Paul Novotny; Winston Tan; Tom R Fitch; Kendrith M Rowland; Charles Y F Young; Patrick J Flynn
Journal: Cancer Date: 2003-03-15 Impact factor: 6.860

Review 3. Nanoparticle therapeutics for prostate cancer treatment.

Authors: Vanna Sanna; Mario Sechi
Journal: Maturitas Date: 2012-02-17 Impact factor: 4.342

4. Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel.

Authors: Nuhad K Ibrahim; Neil Desai; Sewa Legha; Patrick Soon-Shiong; Richard L Theriault; Edgardo Rivera; Bita Esmaeli; Sigrid E Ring; Agop Bedikian; Gabriel N Hortobagyi; Julie A Ellerhorst
Journal: Clin Cancer Res Date: 2002-05 Impact factor: 12.531

5. A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach.

Authors: E Choan; Roanne Segal; Derek Jonker; Shawn Malone; Neil Reaume; Libni Eapen; Victor Gallant
Journal: Urol Oncol Date: 2005 Mar-Apr Impact factor: 3.498

6. Nanochemoprevention by bioactive food components: a perspective.

Authors: Imtiaz A Siddiqui; Hasan Mukhtar
Journal: Pharm Res Date: 2010-03-11 Impact factor: 4.200

7. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study.

Authors: Saverio Bettuzzi; Maurizio Brausi; Federica Rizzi; Giovanni Castagnetti; Giancarlo Peracchia; Arnaldo Corti
Journal: Cancer Res Date: 2006-01-15 Impact factor: 12.701

8. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis.

Authors: I A Siddiqui; A Malik; V M Adhami; M Asim; B B Hafeez; S Sarfaraz; H Mukhtar
Journal: Oncogene Date: 2007-11-12 Impact factor: 9.867

9. Interactions between human glutamate carboxypeptidase II and urea-based inhibitors: structural characterization.

Authors: Cyril Barinka; Youngjoo Byun; Crystal L Dusich; Sangeeta R Banerjee; Ying Chen; Mark Castanares; Alan P Kozikowski; Ronnie C Mease; Martin G Pomper; Jacek Lubkowski
Journal: J Med Chem Date: 2008-12-25 Impact factor: 7.446

Review 10. Nanoparticle therapeutics: an emerging treatment modality for cancer.

Authors: Mark E Davis; Zhuo Georgia Chen; Dong M Shin
Journal: Nat Rev Drug Discov Date: 2008-09 Impact factor: 84.694

16 in total

1. Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer.

Authors: Wenjin Xu; Imtiaz A Siddiqui; Minakshi Nihal; Srikanth Pilla; Kimberly Rosenthal; Hasan Mukhtar; Shaoqin Gong
Journal: Biomaterials Date: 2013-04-11 Impact factor: 12.479

2. Resveratrol-loaded nanoparticles based on poly(epsilon-caprolactone) and poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) blend for prostate cancer treatment.

Authors: Vanna Sanna; Imtiaz Ahmad Siddiqui; Mario Sechi; Hasan Mukhtar
Journal: Mol Pharm Date: 2013-09-04 Impact factor: 4.939

Review 3. Biocompatible and biodegradable nanoparticles for enhancement of anti-cancer activities of phytochemicals.

Authors: Chuan Li; Jia Zhang; Yu-Jiao Zu; Shu-Fang Nie; Jun Cao; Qian Wang; Shao-Ping Nie; Ze-Yuan Deng; Ming-Yong Xie; Shu Wang
Journal: Chin J Nat Med Date: 2015-09

4. Single-step green synthesis and characterization of gold-conjugated polyphenol nanoparticles with antioxidant and biological activities.

Authors: Vanna Sanna; Nicolino Pala; Giuseppina Dessì; Paola Manconi; Alberto Mariani; Sonia Dedola; Mauro Rassu; Claudia Crosio; Ciro Iaccarino; Mario Sechi
Journal: Int J Nanomedicine Date: 2014-10-23